Systematic skin and nasal decolonization lowers Staphylococcus infection in pediatric cardiac surgery

Arch Pediatr. 2022 Apr;29(3):177-182. doi: 10.1016/j.arcped.2022.01.009. Epub 2022 Jan 31.

Abstract

Background: Postoperative infections occur in approximately 10% of pediatric cardiac surgeries, involving Staphylococcus species in most cases. Nasal decontamination of Staphylococcus with mupirocin has been reported to reduce postoperative Staphylococcus infections after cardiac surgery in adults, but the effect of preoperative decontamination in children undergoing cardiac surgery has not been sufficiently studied to reach consensus.

Methods: We conducted a single-center retrospective study to evaluate the impact of systematic preoperative decolonization with intranasal mupirocin application and skin-washing with chlorhexidine soap on postoperative Staphylococcus infection in children undergoing cardiac surgery. Our population was divided into three groups according to decolonization protocol (group N: no decolonization; group T: targeted decolonization in Staphylococcus aureus [SA] carriers only; and group S: systematic decolonization).

Results: A total of 393 children were included between October 2011 and August 2015 (122 in group N, 148 in group T, and 123 in group S). The Staphylococcus infection rate significantly decreased in group S compared to group N (0.8% vs. 7.7%; p < 0.05) and tended to decrease in group S compared to group T (0.8% vs. 4.7%; p = 0.06). Systematic decontamination also significantly reduced the rate of infections starting from the skin (including surgical site infections and bloodstream infections) compared to targeted decolonization or lack of decolonization, but had no effect on the rate of pulmonary infections.

Conclusion: The results of our study suggest that systematic preoperative skin and nasal decontamination, regardless of SA carriage status, could reduce the rate of postoperative Staphylococcus infections after cardiac surgery in children.

Keywords: Antibiotic prophylaxis; Cardiac surgery; Congenital heart disease; Mediastinitis; Postoperative infection; Staphylococcus.

MeSH terms

  • Anti-Bacterial Agents / therapeutic use
  • Cardiac Surgical Procedures* / adverse effects
  • Carrier State
  • Child
  • Humans
  • Retrospective Studies
  • Staphylococcal Infections* / drug therapy
  • Staphylococcal Infections* / prevention & control
  • Staphylococcus aureus
  • Surgical Wound Infection / prevention & control

Substances

  • Anti-Bacterial Agents